Nautilus Biotechnology (NAUT) Earnings Date, Estimates & Call Transcripts $0.73 -0.01 (-1.58%) Closing price 03:58 PM EasternExtended Trading$0.73 0.00 (-0.14%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nautilus Biotechnology Earnings Summary Nautilus Biotechnology issued Q2 2025 earnings on July 31, 2025, reporting an EPS of -$0.12, which topped the consensus estimate of -$0.14 by $0.02. With a trailing EPS of -$0.52, Nautilus Biotechnology's earnings are expected to decrease next year, from ($0.57) to ($0.68) per share. Latest Q2 Earnings DateJul. 31EstimatedConsensus EPS (Jul. 31) -$0.14 Actual EPS (Jul. 31) -$0.12 Beat By $0.02 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Nautilus Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nautilus Biotechnology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNAUT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Nautilus Biotechnology Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.57) EPSNext Year EPS Consensus Estimate ($0.68) EPS Nautilus Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025-$0.14-$0.12+$0.02-$0.12--4/29/2025Q1 2025-$0.14-$0.13+$0.01-$0.13--10/29/2024Q3 2024-$0.17-$0.13+$0.04-$0.13--7/30/2024Q2 2024-$0.16-$0.14+$0.02-$0.14--4/30/2024Q1 2024-$0.16-$0.15+$0.01-$0.15--2/28/2024Q4 2023-$0.16-$0.14+$0.02-$0.14--10/31/2023Q3 2023-$0.18-$0.13+$0.05-$0.13-- Nautilus Biotechnology Earnings - Frequently Asked Questions When did Nautilus Biotechnology announce their last quarterly earnings? Nautilus Biotechnology (NASDAQ:NAUT) last announced its quarterly earning data on Thursday, July 31, 2025. Learn more on NAUT's earnings history. Did Nautilus Biotechnology beat their earnings estimates last quarter? In the previous quarter, Nautilus Biotechnology (NASDAQ:NAUT) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.02. Learn more on analysts' earnings estimate vs. NAUT's actual earnings. How can I listen to Nautilus Biotechnology's earnings conference call? The conference call for Nautilus Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read Nautilus Biotechnology's conference call transcript? The conference call transcript for Nautilus Biotechnology's latest earnings report can be read online. Read Transcript How much profit does Nautilus Biotechnology generate each year? Nautilus Biotechnology (NASDAQ:NAUT) has a recorded net income of -$70.78 million. NAUT has generated -$0.52 earnings per share over the last four quarters. What is Nautilus Biotechnology's EPS forecast for next year? Nautilus Biotechnology's earnings are expected to decrease from ($0.57) per share to ($0.68) per share in the next year. More Earnings Resources from MarketBeat Related Companies Senseonics Earnings Quanterix Earnings Quantum-Si Earnings Frequency Electronics Earnings 908 Devices Earnings Kewaunee Scientific Earnings Rapid Micro Biosystems Earnings Seer Earnings Owlet Earnings Prenetics Global Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Dutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline This page (NASDAQ:NAUT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nautilus Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
